用户名： 密码： 验证码：
Insomnia: the Sleeping Giant of Pediatric Public Health
详细信息    查看全文
  • 作者：Emily Badin ; Cynthia Haddad ; Jess Parker Shatkin
  • 关键词：Children ; Adolescent ; Pediatric insomnia ; Sleep ; Cognitive behavior therapy for insomnia
  • 刊名：Current Psychiatry Reports
  • 出版年：2016
  • 出版时间：May 2016
  • 年：2016
  • 卷：18
  • 期：5
  • 全文大小：991 KB
  • 参考文献：1.Owens J. Classification and epidemiology of childhood sleep disorders. Prim Care. 2008;35:533–46.CrossRef PubMed
    2.Archbold KH, Pituch KJ, Panabi P, Chervin RD. Symptoms of sleep disturbances among children at two general pediatric clinics. J Pediatr. 2002;140:97–102.CrossRef PubMed
    3.Amschler DH, McKenzie JF. Elementary students’ sleep habits and teacher observations of sleep-related problems. J Sch Health. 2005;75:50–6.CrossRef PubMed
    4.Meltzer LJ, Johnson C, Crosette J, Ramos M, Mindell JA. Prevalence of diagnosed sleep disorders in pediatric primary care practices. Pediatrics. 2010;125:1410–7.CrossRef
    5.Sadeh A. Cognitive-behavioral treatment for childhood sleep disorders. Clin Psychol Rev. 2005;25:612–28.CrossRef PubMed
    6.Rosen RC, Zozula R, Jahn EG, Carson JL. Low rates of recognition of sleep disorders in primary care: comparison of a community-based versus clinical academic setting. Sleep Med. 2001;2:47–55. doi:10.​1016/​s1389-9457(00)00043-5 .CrossRef PubMed
    7.National Sleep Foundation. What is insomnia? In: Insomnia. 2014. Retrieved from: http://​sleepfoundation.​org/​insomnia/​content/​what-is-insomnia . Accessed 9 March 2016.
    8.•
Honaker SM, Meltzer LJ. Sleep in pediatric primary care: a review of the literature. Sleep Med Rev. 2015;1–9. doi: 10.​1016/​j.​smrv.​2015.​01.​004 . An important review of literature highlighting the high prevalence rates of insomnia among children and adolescents.
9.Owens JA, Rosen CL, Mindell JA, Kirchner HL. Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey. Sleep Med. 2010;11:692–700.CrossRef PubMed
10.Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ. 2012;345:1–13.CrossRef
11.Owens JA. The practice of pediatric sleep medicine: results of a community survey. Pediatrics. 2001;108:e51.CrossRef PubMed
12.Owens JA, Dalzell V. Use of the “BEARS” sleep screening tool in pediatric residents’ continuity clinic: a pilot study. Sleep Med. 2005;6:63–9.CrossRef PubMed
13.Byars KC, Yolton K, Rausch J, Lanphear B, Beebe DW. Prevalence, patterns, and persistence of sleep problems in the first 3 years of life. Pediatrics. 2012;129:276–84. doi:10.​1542/​peds.​2011-0372 .CrossRef
14.Luginbuehl M, Kohler WC. Screening and evaluation of sleep disorders in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2009;18:825–38. doi:10.​1016/​j.​chc.​2009.​04.​012 .CrossRef PubMed
15.Tikotzky L, Sadeh A. The role of cognitive-behavioral therapy in behavioral child insomnia. Sleep Med. 2010;11:686–91.CrossRef PubMed
16.Taylor DJ, Roane BM. Treatment of insomnia in adults and children: a practice-friendly review of research. J Clin Psychol. 2010;66:1137–47. doi:10.​1002/​jclp.​20733 .CrossRef PubMed
17.National Sleep Foundation. What is sleep hygiene? Sleep Hygiene. 2015. Retrieved from: http://​sleepfoundation.​org/​ask-the-expert/​sleep-hygiene . Accessed 9 March 2016.
18.Borbély AA. A two process model of sleep regulation. Hum Neurobiol. 1982;1:195–204.PubMed
19.•
Shatkin JP, Pando M. Diagnosis and treatment of common sleep disorders in adolescence. Adolesc Psychiatr. 2015;4:1–13. A vast review of the literature related to sleep disorders in adolescence and the common approaches to treating them.
20.Roehrs T, Roth T. Sleep, sleepiness, and alcohol use. Natl Inst Alcohol Abuse Alcoholism. 2001;25(2):101–9.
21.•
Krystal AD. Psychiatric disorders and sleep. Neurol Clin. 2012;30:1389–413. A review of the literature showing the negative effects of alcohol consumption on sleep.CrossRef PubMed PubMedCentral
22.Landolt HP, Roth C, Dijk DJ, Borbely AA. Late-afternoon ethanol intake affects nocturnal sleep and the sleep EEG in middle-aged men. J Clin Psychopharmacol. 1996;16:428–36.CrossRef PubMed
23.Roehrs T, Roth T. Caffeine: sleep and daytime sleepiness. Sleep Med Rev. 2008;12:153–62.CrossRef PubMed
24.Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci (CMLS). 2004;61:857–72.CrossRef
25.Fuller PM, Gooley JJ, Saper CB. Neurobiology of the sleep-wake cycle: sleep architecture, circadian rhythm, and regulatory feedback. J Biol Rhythms. 2006;6:482–93.CrossRef
26.Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of sleep and wakefulness. Sleep Med Clin. 2010;5:513–28.CrossRef PubMed PubMedCentral
27.Harrison N, Mendelson WB, de Wit H. Barbiturates. Psychopharmacol—the fourth generation of progress. 2000. Retrieved from: http://​www.​acnp.​org/​g4/​GN401000173/​CH169.​html . Accessed 9 March 2016.
28.Bianchi MT, Botzolakis EJ, Lagrange AH, Macdonald RL. Benzodiazepine modulation of GABAA receptor opening frequency depends on activation context: a patch clamp and simulation study. Epilepsy Res. 2009;85:212–20.CrossRef PubMed PubMedCentral
29.Beck Institute for Cognitive Behavior Therapy (n.d.) Cognitive behavior therapy. Retrieved from: https://​www.​beckinstitute.​org/​ .Accessed 9 March 2016.
30.Ferber R. Childhood sleep disorders. Neurol Clin. 1996;3:493–511.CrossRef
31.Knab B, Engel RR. Perception of waking and sleeping: possible implications for the evaluation of insomnia. Sleep. 1988;11:265–72.PubMed
32.Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med. 1995;1:6–11. doi:10.​1056/​nejm199501053320​102 .CrossRef
33.Siebern AT, Manber RM. New developments in cognitive behavioral therapy as the first-line treatment of insomnia. Psychol Res Behav Manag. 2011;4:21–8.CrossRef PubMed PubMedCentral
34.Paine S, Gradisar M. A randomised controlled trial of cognitive-behaviour therapy for behavioural insomnia of childhood in school-aged children. Behav Res Ther. 2011; (6–7):379–88. doi:10.​1016/​j.​brat.​2011.​03.​008 .
35.Ferguson SA, Rajaratnam SM, Dawson D. Melatonin agonists and insomnia. Expert Rev Neurother. 2010;10:305–18. doi:10.​1586/​ern.​10.​1 .CrossRef PubMed
36.van Geijlswijk IM, Korzilius HPLM, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010;33:1605–14.PubMed PubMedCentral
37.Regestein QR, Monk TH. Delayed sleep phase syndrome: a review of its clinical aspects. Am J Psychiatry. 1995;152:602–8.CrossRef PubMed
38.van der Heijden KB, Smits MG, van Someren EJ, Gunning WB. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia. J Sleep Res. 2005;14:187–94.CrossRef PubMed
39.Prince JB, Wilens TE, Biederman J, Spencer TJ, Wozniak JR. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35:599–605. doi:10.​1097/​00004583-199605000-00014 .CrossRef PubMed
40.Wilens TE, Biederman J, Spencer TJ, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder. J Clin Psychopharmacol. 1995;15:270–9. doi:10.​1097/​00004714-199508000-00006 .CrossRef PubMed
41.Brielmaier BD. Eszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agent. Proc (Baylor Univ Med Cent). 2006;19:54–9.
42.Lahmeyer H, Wilcox H, Kann A, Leppik I. Subjective efficacy of zolpidem in outpatients with chronic insomnia: a double-blind comparison with placebo. Clin Drug Investig. 1997;13:134–44.CrossRef
43.Russo R, Gururaj V, Allen J. The effectiveness of diphenhydramine HC1 in pediatric sleep disorders. J Clin Pharmacol. 1976;16:284–8.CrossRef PubMed
44.Merenstein D, Diener-West M, Halbower AC, Krist A, Rubin HR. The trial of infant response to diphenhydramine: the TIRED study—a randomized controlled, patient-oriented trial. Arch Pediatr Adolesc Med. 2006;160:707–12.CrossRef PubMed
45.Müller S, Klement S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine. 2006;13:383–7. doi:10.​1016/​j.​phymed.​2006.​01.​013 .CrossRef PubMed
46.Francis A, Dempster R. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomised trial. Phytomedicine. 2002;9:273–9. doi:10.​1078/​0944-7113-00110 .CrossRef PubMed
47.Perlis ML, Jungquist C, Smith MT, Posner D. Cognitive behavioral treatment of insomnia: a session-by-session guide. New York: Springer-Verlag; 2005.
  • 作者单位：Emily Badin (1)
    Cynthia Haddad (1)
    Jess Parker Shatkin (1)

    1. The Child Study Center at NYU Langone Medical Center, One Park Ave, 7th Floor, New York, NY, 10016, USA
  • 刊物主题：Psychiatry;
  • 出版者：Springer US
  • ISSN：1535-1645
    • 文摘
    Insomnia among children and adolescents is ubiquitous and takes a great toll on youth and their families, impacting academic achievement, mood, social functioning, and a variety of developmental outcomes. Unfortunately, however, pediatric insomnia most often remains unidentified and untreated. When treatment is provided, it is most often in the form of medications, which are not FDA approved for that indication in children and adolescents. A comprehensive literature review was employed to establish the recommendations in this report. This article provides a review of sleep physiology and both current and recommended approaches to assessing and treating pediatric insomnia. Comprehensive assessment, accurate diagnosis, and evidence-based treatment of insomnia is imperative to the healthy development of children and adolescents. While clinicians often prescribe a variety of medications to treat pediatric insomnia, there is insufficient data to demonstrate efficacy and endorse their routine use. At this time, behavioral techniques, such as cognitive behavior therapy for insomnia and sleep hygiene education, should remain the first line of treatment. As a second-line consideration, melatonin, a dietary supplement, may be effective. Pediatric insomnia has an enormous impact on children, adolescents, and their families that requires adequate attention from clinicians and parents alike.

    © 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

    地址：北京市海淀区学院路29号 邮编：100083

    电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700